Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors Predicting Hospital Stays of Patients with Advanced Cancer Receiving Morphine and Its Derivatives
TCTR20181120002Phase 0Recruiting
- Sponsor
- Chulabhorn Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, open-label, single-arm trial of morphine in cancer, sponsored by Chulabhorn Hospital. Primary endpoint: Length of hospital stay. Started Oct 2018; status: recruiting.
02
Drugs
morphine
03
Conditions
cancer
Beyond the preview
Go deeper on TCTR20181120002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20181120002.